Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
Purpose
The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components used to treat PTSD? What do these components change to produce benefits in PTSD? Researchers will: Compare components to a psychological placebo to estimate their effects and measure how they work Examine how components work alone and in conjunction with other components Participants will: Receive different combinations of components and placebo Attend weekly treatment sessions Provide information to evaluate changes in PTSD
Conditions
- PTSD
- Trauma
- Pediatric ALL
Eligibility
- Eligible Ages
- Between 8 Years and 17 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
A child between the ages of 8-17 exposed to at least one DSM-defined trauma Child assent for participation The participation of a caregiver with custodial rights to provide parental permission Willing to participate in treatment delivery and respond to surveys Meet PTSD diagnostic criteria that is the result of exposure to at least one of the identified traumas Ability to read and understand English Willingness to be randomized to an experimental condition Placement in a stable caregiving environment for two months without an impending transition Children currently taking psychotropic medications must have taken the medicine without dose adjustment for two months prior to study entry. Caregiver or child with a smartphone capable of downloading a freely available software application.
Exclusion Criteria
Psychiatric concerns requiring a higher level of care (e.g. suicidal ideation with intent; current psychotic disorder) An intelligence quotient (IQ) < 70 Currently receiving a behavioral health intervention for concerns related to PTSD or pediatric trauma A participating caregiver who is a perpetrator of any identified trauma (e.g. sexual abuse) MRI contraindicators (e.g. presence of metal in the body)
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Factorial Assignment
- Intervention Model Description
- 2^4 Full Factorial Randomized Clinical Trial
- Primary Purpose
- Treatment
- Masking
- Triple (Participant, Investigator, Outcomes Assessor)
- Masking Description
- Independent and masked raters of treatment fidelity; Independent and masked raters of processes of change during active treatment
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Treatment Condition 1 |
Participants receive emotion regulation, exposure, cognitive processing, and bi-lateral stimulation |
|
|
Experimental Treatment Condition 2 |
Participants receive emotion regulation, exposure, cognitive processing, and psychological placebo |
|
|
Experimental Treatment Condition 3 |
Participants receive emotion regulation, exposure, bi-lateral stimulation, and psychological placebo |
|
|
Experimental Treatment Condition 4 |
Participants receive emotion regulation, exposure, and psychological placebo |
|
|
Experimental Treatment Condition 5 |
Participants receive emotion regulation, cognitive processing, bi-lateral stimulation, and psychological placebo |
|
|
Experimental Treatment Condition 6 |
Participants receive emotion regulation, cognitive processing, and psychological placebo |
|
|
Experimental Treatment Condition 7 |
Participants receive emotion regulation, bi-lateral stimulation, and psychological placebo |
|
|
Experimental Treatment Condition 8 |
Participants receive emotion regulation and psychological placebo |
|
|
Experimental Treatment Condition 9 |
Participants receive exposure, cognitive processing, bi-lateral stimulation, and psychological placebo |
|
|
Experimental Treatment Condition 10 |
Participants receive exposure, cognitive processing, and psychological placebo |
|
|
Experimental Treatment Condition 11 |
Participants receive exposure, bi-lateral stimulation, and psychological placebo |
|
|
Experimental Treatment Condition 12 |
Participants receive exposure and psychological placebo |
|
|
Experimental Treatment Condition 13 |
Participants receive cognitive processing, bi-lateral stimulation, and psychological placebo |
|
|
Experimental Treatment Condition 14 |
Participants receive cognitive processing and psychological placebo |
|
|
Experimental Treatment Condition 15 |
Participants receive bi-lateral stimulation and psychological placebo |
|
|
Experimental Treatment Condition 16 |
Participants receive psychological placebo |
|
Recruiting Locations
More Details
- Status
- Recruiting
- Sponsor
- University of Rochester